APRIORI BIO
Apriori Bio is a health security company, aimed at protecting humanity against viral threats. The company uses a unique technology platform that enables the creation of variant-resilient vaccines and provides real-time insights to prepare for future outbreaks. Apriori Bio focuses on designing new vaccines and antibody drugs to combat existing and potential viral variants. With its innovative approach, the company aims to ensure durable protection against rapidly evolving viruses
APRIORI BIO
Industry:
Biotechnology Clinical Trials Life Science Medical
Founded:
2020-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.aprioribio.com
Total Employee:
11+
Status:
Active
Total Funding:
51.1 M USD
Technology used in webpage:
Google Google Cloud COVID-19
Similar Organizations
Advanced Regenerative Manufacturing Institute
Advanced Regenerative Manufacturing Institute is a member-based nonprofit organization.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
LyGenesis
LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Daniel Acker Cofounder & Chief Innovation Officer @ Apriori Bio
Cofounder & Chief Innovation Officer
2020-01-01
Noubar Afeyan Co-Founder & Chairman @ Apriori Bio
Co-Founder & Chairman
2021-08-01
Lovisa Afzelius Co-founder & CEO @ Apriori Bio
Co-founder & CEO
2020-10-01
Alex Goldsmith Co-Founder & Chief Operating Officer @ Apriori Bio
Co-Founder & Chief Operating Officer
2020-10-01
Founder
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - Apriori Bio
Flagship Pioneering
Flagship Pioneering investment in Series A - Apriori Bio
Official Site Inspections
http://www.aprioribio.com Semrush global rank: 11.52 M Semrush visits lastest month: 156
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Apriori Bio"
About - Apriori Bio
Craig Williams, MBA Chief Executive Officer, Apriori Bio CEO-Partner, Flagship PioneeringSee details»
Apriori Bio - Crunchbase Company Profile & Funding
Contact Email info@aprioribio.com Apriori Bio is a health security company, aimed at protecting humanity against viral threats. The company uses a unique technology platform that enables …See details»
Apriori Bio - LinkedIn
Apriori is working to create a world where humanity is protected against viral threats. Our pioneering approach centers on a unique technology platform, which allows us to survey the entire ...See details»
Flagship Pioneering Launches Apriori Bio to… | Flagship Pioneering
Jul 11, 2022 The company will prioritize viruses of concern to the World Health Organization, starting with SARS-CoV-2, Influenza and HIV before exploring further options. ... Apriori was …See details»
Apriori Bio 2025 Company Profile: Valuation, Funding
Apriori Bio General Information Description. Operator of a health security company intended to protect against viral threats. The company's approach …See details»
Apriori Bio - Company Profile & Staff Directory - ContactOut
About Apriori Bio. Apriori is working to create a world where humanity is protected against viral threats. Our pioneering approach centers on a unique technology platform, which allows us to …See details»
Apriori Bio - Craft
Apriori Bio is a biotech company that develops vaccines that protect against viral threats. It offers Octavia, a biology-enabled AI platform that generates landscape maps of a virus's existing and …See details»
Flagship Pioneering Appoints Craig Williams as… | Flagship …
Nov 13, 2024 Octavia can also inform public health policy in real time by predicting the impact of emerging variants. Apriori was founded in 2020 in Flagship Labs, a unit of Flagship …See details»
Apriori Bio
With a unique technology platform that enables variant-resilient vaccines and actionable real-time insights, Apriori is learning from today’s viruses to prepare for tomorrow’s outbreaks.See details»
Apriori Bio - Flagship Pioneering
Jul 11, 2022 Apriori Bio is working to create a world where humanity is protected against viral threats. The company’s pioneering approach centers on its unique technology …See details»
Apriori Bio Appoints World-Class Vaccine, Immunology and Public …
Sep 24, 2024 Seth Berkley, M.D., Arup Chakraborty, Ph.D., and Ashish Jha, M.D., MPH, join the Board CAMBRIDGE, Mass., Sept. 24, 2024 /PRNewswire/ -- Apriori Bio, a biotechnology …See details»
Apriori Bio Named 2023 Technology Pioneer by World Economic …
Jun 21, 2023 For more information visit www.aprioribio.com or follow us on LinkedIn and Twitter at @ AprioriBio. ... is the International Organization for Public-Private Cooperation. The Forum …See details»
Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof ...
Jul 11, 2022 Following more than two years of development, Flagship unveils Apriori Bio with $50 million of committed capital. CAMBRIDGE, Mass., July 11, 2022 /PRNewswire/ -- Flagship …See details»
Apriori Bio - edgein.io
Apriori is working to create a world where humanity is protected against viral threats. Our pioneering approach centers on a unique technology platform, which allows us to survey the …See details»
Apriori Bio
Nov 13, 2024 Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori BioSee details»
Apriori Bio - workinbiotech.com
Apriori Bio is learning about viruses present today to prepare for outbreaks in the future. The most threatening viruses can evolve faster than new medicines can be developed. To solve this, …See details»
2025 CEO Chat: Craig Williams, CEO of Apriori… | Flagship Pioneering
Apriori CEO Craig Williams shares updates on the company’s platform and pipeline of variant-resilient vaccines including how Apriori is harnessing top talent across development, …See details»
Apriori Bio
Jul 11, 2022 Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral ThreatsSee details»
Science - Apriori Bio
…that protects not only against variants in circulation today, but against those that will emerge in the coming weeks, months, and even years. Imagine a world where public health policy is …See details»
News - Apriori Bio
Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral ThreatsSee details»